An interventional study of Community Aging in Place-Advancing Better Living for Elders in Functional Limitations, Activities of Daily Living and Aging, sponsored by University of Southern California. Not yet recruiting at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by University of Southern California · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 134 studies in Patient Acceptance of Health Care with a site in United States — 24 open to participants now, 35 under way, 1 of them phase 3. Patient Acceptance of Health Care · United States.
Among the 134 studies in Patient Acceptance of Health Care with a site in United States, this one is the 28th largest by planned enrollment of the 109 interventional ones that give a count, is the only one that started in 2027, is one of 100 with no phase, reaches primary completion later than 30 of the 34 other live ones, and was the 134th registered.
309 studies on the registry are indexed under Patient Acceptance of Health Care; 54 are open to participants now.
Browse Patient Acceptance of Health Care studies →24 of the 134 studies in Patient Acceptance of Health Care with a site in United States are open now. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 18+
Northwestern University · Sites in United States
Healthy volunteers
Cedars-Sinai Medical Center · Sites in United States
Ages 18–99
Andrea Wallace · Sites in United States
Ages 18+ · Healthy volunteers
North Carolina State University · Sites in United States
Ages 8–64 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 34 Patient Acceptance of Health Care studies recruiting now, 22 (65%) set no upper age limit and 9 (26%) stop at 75 or younger; 11 take children under 18; 16 take healthy volunteers.
This study: 45 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
134 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 5 · Phase 4 2
First in 1998; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 634 is above the median of 202 across 218 interventional studies indexed under Patient Acceptance of Health Care.
Median enrollment 264 across the 109 interventional studies, 646 across the 24 observational. Of the 91 that completed or were terminated, 34 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 134 have an industry lead sponsor. The 10 most frequent:
University of Southern California is the lead sponsor of 793 studies on the registry; 138 are open to participants now.
Of its 71 completed or terminated interventional studies of FDA-regulated products, 32 (45%) have results posted.
University of Southern California has 1 study filed under Patient Acceptance of Health Care — fewer than ten, so there is no comparison to draw.
13 of the studies in Patient Acceptance of Health Care with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07217145Phase 3University of UtahPREVENT HPV -Related Cancers Trial | 2026-11 |
| NCT05558332University of California, IrvineYouth Nominated Support Team | 2026-11 |
| NCT05605054Victoria D. OjedaUCSD RELINK: Connecting Adults To Supportive Services | 2026-12-31 |
| NCT06019377Portland State UniversityIntervention to Enhance Coping and Help-seeking Among Youth in Foster Care | 2026-12-31 |
| NCT07542769Northwestern UniversityChoice and Autonomy in Learning Mindfulness for Pediatric Residents | 2026-12-31 |
Add all 13 to your calendar (.ics) → With an account.
Among the 134 studies in Patient Acceptance of Health Care with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will evaluate whether Community Aging in Place-Advancing Better Living for Elders (CAPABLE) improves daily functioning among adults aged 45 years and older who live in permanent supportive housing and have difficulty performing everyday activities.
Participants will be randomly assigned to receive either CAPABLE in addition to their usual services or usual services alone. CAPABLE is a person-directed, home-based program delivered by an occupational therapist and a registered nurse. Participants assigned to CAPABLE may receive up to 10 home visits over approximately six months, including up to six occupational therapy visits and four nursing visits. Assistive devices and minor home modifications may also be provided based on each participant's goals and needs.
The study will enroll approximately 634 participants in Los Angeles County. Researchers will assess participants at enrollment and at 3, 6, 9, and 12 months. The main outcomes are participants' ability to perform activities of daily living and instrumental activities of daily living. The study will also examine health-related quality of life, health care use, housing stability, and the cost-effectiveness of CAPABLE.
This randomized effectiveness trial will examine the effectiveness and cost-effectiveness of CAPABLE when delivered to adults living in permanent supportive housing. CAPABLE is a person-directed intervention designed to address functional limitations by integrating occupational therapy, nursing, assistive devices, and minor home modifications.
Approximately 634 participants will be randomly assigned in a 1:1 ratio to the CAPABLE intervention group or the usual-care control group. Participants assigned to CAPABLE will receive the intervention in addition to the health and supportive services normally available to them. The intervention may include up to six occupational therapy visits and four registered nursing visits over approximately six months. The occupational therapist and nurse will work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services will be provided when appropriate. Participants assigned to the control group will continue to receive their usual services.
Study assessments will occur at baseline and at 3, 6, 9, and 12 months. Full outcome assessments will be conducted at baseline, 6 months, and 12 months, with shorter assessments of health care utilization and health-related quality of life at 3 and 9 months. The primary outcomes are limitations in activities of daily living and instrumental activities of daily living. Additional outcomes include health-related quality of life, health care utilization, housing stability, and intervention costs.
Outcome assessors will be masked to participants' treatment assignments. The economic evaluation will compare intervention costs with changes in health-related quality of life and health care utilization to estimate the cost-effectiveness of CAPABLE relative to usual care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to this arm will receive CAPABLE in addition to their usual health and supportive services. CAPABLE is a person-directed, home-based intervention delivered over approximately six months and may include up to six occupational therapy visits and four registered nursing visits. Assistive devices, minor home modifications, and coordination with existing services may be provided based on each participant's goals and needs.
Behavioral: Community Aging in Place-Advancing Better Living for Elders
Participants assigned to this arm will continue to receive the health and supportive services normally available to them and will not receive the CAPABLE intervention during the study.
CAPABLE is a person-directed, home-based behavioral intervention designed to improve participants' ability to perform everyday activities. The intervention is delivered over approximately six months and may include up to six visits from an occupational therapist and four visits from a registered nurse. The occupational therapist and nurse work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services may be provided as appropriate based on each participant's goals and needs.
Change in Activities of Daily Living Limitations
Activities of daily living will be assessed using an 8-item scale measuring difficulty with basic daily activities. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.
Time frame: Baseline, 6 months, and 12 months
Change in Instrumental Activities of Daily Living Limitations
Instrumental activities of daily living will be assessed using the 8-item Brief Instrumental Functioning Scale. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.
Time frame: Baseline, 6 months, and 12 months
Quality-Adjusted Life Years
Health-related quality of life will be measured using the five-item EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Responses will be converted to health-state utility values and used to calculate quality-adjusted life years over the 12-month follow-up period. Higher quality-adjusted life years indicate better health outcomes.
Time frame: Baseline and 3, 6, 9, and 12 months
Health Care Utilization
Health care utilization during the preceding three months will be assessed using the 12-item UCSD Healthcare Utilization Questionnaire. Participants will report their use of inpatient hospital care, surgery, nursing home care, emergency department care, ambulance services, outpatient health care, home care, telephone or online health care, prescription medications, and over-the-counter medications. Utilization will be compared between study arms and used to estimate health care costs.
Time frame: Baseline and 3, 6, 9, and 12 months
Incremental Cost-Effectiveness of CAPABLE
Incremental cost-effectiveness ratios will compare CAPABLE with usual care. Ratios will be calculated by dividing the difference between study arms in intervention and health care costs by the corresponding differences in activities of daily living limitations, instrumental activities of daily living limitations, and quality-adjusted life years. Lower costs per unit of improvement indicate greater cost-effectiveness.
Time frame: From baseline through 12 months
Plan to share: Yes — A deidentified quantitative individual participant dataset will be shared. The study protocol, survey instruments, and data dictionary will also be made available to facilitate interpretation and reuse of the data. The dataset and associated documentation will be deposited in the National Archive of Computerized Data on Aging (NACDA), which is part of ICPSR.
Supporting information: Study protocol
Time frame: The IPD and supporting information will become available following completion of the planned study analyses and no later than August 31, 2031. Materials deposited in NACDA will remain available indefinitely.
Access criteria: Researchers will be able to access the deidentified individual participant dataset and supporting documentation through NACDA within ICPSR at no charge. Users must agree to the repository's terms of use, including limiting use to research or statistical purposes, not attempting to identify participants, not redistributing downloaded data, and properly citing the dataset.
No publications or documents are linked to this record.
Start is estimated for Mar 2027; primary completion for Aug 2029, 29 months later.
Of 151 non-industry interventional studies with no phase under Patient Acceptance of Health Care, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's planned 29 months is above that.
Counting every sponsor, half of 154 studies reached it within 19 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patient Acceptance of Health Care →
University of Southern California →